Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 30, 2026
TickeronGET DAILY SIGNALS
GXPS vs IYK: Weighing Lower Costs Against Liquidity in Consumer Staples ETFs

GXPS vs IYK: Weighing Lower Costs Against Liquidity in Consumer Staples ETFs

Key Takeaways

  • Both funds are passively managed consumer staples ETFs, but GXPS is a pure-play, uncapped market-cap strategy while IYK uses a capped index with a modest healthcare and materials tilt.
  • GXPS is materially cheaper, with a 0.15% net expense ratio versus roughly 0.37%–0.40% for IYK.
  • GXPS is more concentrated (around 31–34 holdings, top 10 near 81%), whereas IYK holds roughly 53–59 names and caps single-stock weight at 22.5%.
  • IYK offers superior liquidity and a longer track record (launched in 2000, roughly $1.4 billion in assets), while GXPS is newer (2025) with a smaller asset base.
  • Performance drivers diverge: GXPS leans into mega-cap retailers like WMT and COST, while IYK adds defensive healthcare exposure through names like MCK and CVS.
  • Tickeron AI Verdict: GXPS — favored for its lower cost and concentrated, uncapped exposure to the sector's strongest leaders.

Why Compare These Two Staples ETFs?

Consumer staples remain a defensive cornerstone in many portfolios, covering essentials like food, beverages, and household goods that hold up across economic cycles. Comparing GXPS and IYK feels relevant now as investors balance pure sector focus with broader diversification, alongside cost considerations versus liquidity, amid evolving inflation and rate outlooks. These funds target similar defensive U.S. equity goals yet differ meaningfully in structure, fees, and holdings, making them distinct choices rather than direct substitutes.

Understanding GXPS

GXPS tracks the MSCI USA Consumer Staples Index with uncapped, free-float market-cap exposure to U.S. companies in the GICS Consumer Staples sector. Launched in July 2025, the non-diversified, passively managed ETF relies on representative sampling. Its key trait is the lack of company caps, allowing the largest names to lead the portfolio. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. The fund typically holds 31–34 securities, with the top 10 accounting for roughly 81% of assets. Leading positions include WMT near 16–17%, COST around 14%, PG near 11–12%, KO around 11%, and PM near 10%. Allocation stays essentially 99–100% in consumer staples. The net expense ratio stands at 0.15% (gross 0.25%), among the lowest in the category, though assets remain modest.

Understanding IYK

IYK, launched in June 2000 by BlackRock, follows the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index. The benchmark caps any single issuer at 22.5% and the group above 4.5% at 45% during quarterly rebalances, resulting in a more balanced mix than an uncapped approach. It too is a non-diversified, passively managed product. The fund generally holds 53–59 securities, with top holdings such as PG and KO each near 13%, PM around 11.5%, PEP near 7%, and MO about 4%. Notably, IYK incorporates healthcare distributors like MCK and CVS, contributing roughly 13% healthcare exposure plus a small materials allocation. Its expense ratio runs about 0.37%–0.40%, with assets exceeding $1.3 billion and solid liquidity.

The Broader Consumer Staples Landscape

Both ETFs sit within a sector known for defensive, non-cyclical earnings. Recent cycles have rewarded pricing power in food and household products amid persistent inflation, while higher rate expectations have boosted appeal for lower-volatility dividend payers. Margin pressures from input costs and wage growth, along with consumer trade-down trends, pose ongoing risks. Regulatory issues around tobacco and beverages, plus antitrust focus on large retailers, add sector-level concerns. This setting tends to favor established mega-cap leaders with scale and pricing strength, which GXPS weights most heavily.

How Performance and Positioning Stack Up

Recent periods show both funds following a defensive path, yet their structures drive noticeable differences in returns. GXPS concentrates in WMT and COST, amplifying gains during staples leadership phases, while its 0.15% fee supports long-term compounding. IYK spreads exposure more evenly and includes healthcare, which can moderate volatility but may temper pure staples momentum. IYK carries a 3-year beta near 0.32–0.35, among the lowest for equity funds, and GXPS delivers comparable defensiveness with greater single-name concentration. Overall positioning leans toward GXPS for trend-focused, cost-sensitive approaches and IYK where diversification and liquidity take priority.

Enhancing ETF Research with AI Tools

In my own analysis of these funds, I frequently turn to Tickeron’s AI Screener to quickly filter holdings, compare expense ratios, and assess concentration levels across similar ETFs. It helps surface structural differences efficiently and supports more informed decisions without manual effort. The tool has become a regular part of how I evaluate sector-specific options like these.

Tickeron AI Verdict

Structural factors point Tickeron’s AI toward favoring GXPS here. Its lower expense ratio, pure consumer staples focus, and uncapped weighting in high-momentum names like WMT and COST fit well with cost-efficient, trend-aligned positioning. While IYK provides better liquidity, broader diversification, and a longer history, its higher fees and healthcare tilt reduce its edge in a pure staples context. This view remains probabilistic and based on current characteristics rather than forecasts of future performance.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IYK, GXPS

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


IYK's RSI Indicator recovers from overbought zone

The 10-day RSI Oscillator for IYK moved out of overbought territory on October 23, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 instances where the indicator moved out of the overbought zone. In 31 of the 38 cases the stock moved lower in the days that followed. This puts the odds of a move down at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IYK as a result. In 61 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

The Moving Average Convergence Divergence Histogram (MACD) for IYK turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 30 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

IYK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.

Following a +1.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 266 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

The Aroon Indicator entered an Uptrend today. In 229 of 305 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.

Notable companies

The most notable companies in this group are Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), Philip Morris International (NYSE:PM), PepsiCo (NASDAQ:PEP), Altria Group (NYSE:MO), McKesson Corp (NYSE:MCK), CVS HEALTH Corp (NYSE:CVS), Mondelez International (NASDAQ:MDLZ), Colgate-Palmolive Company (NYSE:CL), Kroger Co (The) (NYSE:KR).

Industry description

The investment seeks to track the investment results of the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index composed of U.S. equities in the consumer staples sector. The fund generally will invest at least 80% of its assets in the component securities of its underlying index, The underlying index measures the performance of the consumer staples sector of the U.S. equity market. It is non-diversified.

Market Cap

The average market capitalization across the iShares U.S. Consumer Staples ETF (IYK) ETF is 49.78B. The market cap for tickers in the group ranges from 3.09B to 411.62B. KO holds the highest valuation in this group at 411.62B. The lowest valued company is FRPT at 3.09B.

High and low price notable news

The average weekly price growth across all stocks in the iShares U.S. Consumer Staples ETF (IYK) ETF was -3%. For the same ETF, the average monthly price growth was 2%, and the average quarterly price growth was 8%. TSN experienced the highest price growth at 11%, while USD experienced the biggest fall at -36%.

Volume

The average weekly volume growth across all stocks in the iShares U.S. Consumer Staples ETF (IYK) ETF was 18%. For the same stocks of the ETF, the average monthly volume growth was 72% and the average quarterly volume growth was 77%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 49
Price Growth Rating: 46
SMR Rating: 58
Profit Risk Rating: 72
Seasonality Score: 13 (-100 ... +100)
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.